Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
14.25
Oct 21 • 5:36 AM ET Dollar change+0.04 Percentage change(0.28%)
Index
RUT
Market Cap
977.20M
Enterprise Value
3.93B
Income
-1.05B
Sales
2.67B
Book/sh
25.99
Cash/sh
1.80
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
6500
IPO
Feb 01, 1991
P/E
-
Forward P/E
9.98
PEG
-
P/S
0.37
P/B
0.55
P/C
7.92
P/FCF
-
EV/EBITDA
9.28
EV/Sales
1.47
Quick Ratio
0.76
Current Ratio
1.39
Debt/Eq
1.73
LT Debt/Eq
1.51
Option/Short
Yes / Yes
EPS (ttm)
-15.41
EPS next Y
1.43
EPS next Q
0.20
EPS this Y
-63.61%
EPS next Y
85.11%
EPS next 5Y
-4.59%
EPS past 3/5Y
- -
Sales past 3/5Y
-5.81% 10.42%
EPS Y/Y TTM
-135.75%
Sales Y/Y TTM
-2.57%
EPS Q/Q
63.94%
Sales Q/Q
2.45%
Insider Own
0.90%
Insider Trans
0.00%
Inst Own
116.93%
Inst Trans
-9.94%
ROA
-17.34%
ROE
-45.91%
ROIC
-23.49%
Gross Margin
37.68%
Oper. Margin
-1.16%
Profit Margin
-39.21%
SMA20
15.45%
SMA50
10.75%
SMA200
-15.94%
Trades
Shs Outstand
68.30M
Shs Float
67.96M
52W High
35.58 -59.94%
52W Low
9.92 43.65%
Volatility
8.01% 7.15%
ATR (14)
0.87
RSI (14)
62.00
Beta
0.82
Rel Volume
0.00
Avg Volume
1.67M
Volume
136
Perf Week
2.74%
Perf Month
30.26%
Perf Quarter
-14.05%
Perf Half Y
19.75%
Perf YTD
-50.11%
Perf Year
-52.23%
Perf 3Y
-78.79%
Perf 5Y
-89.36%
Perf 10Y
-33.10%
Prev Close
14.21
Price
14.25
Change %
0.28%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Siegrist Jonathan PhilipEVP of R&D & CTOOct 15 '26Option Exercise0.0018,657032,076Oct 19 05:07 PM
Bowman Ronald LeeChief Human Resources OfficerSep 15 '26Option Exercise0.002,56605,941Sep 17 06:32 PM
Hanson Bryan MichaelEVP Global Port. Mgmt & MktingAug 15 '26Option Exercise0.0044608,217Aug 18 04:14 PM
Hanson Bryan MichaelEVP Global Port. Mgmt & MktingJul 01 '26Option Exercise0.005,79709,867Jul 02 04:06 PM
Strobeck MatthewDirectorFeb 13 '26Buy23.9610,000239,58627,775Feb 13 04:20 PM
Busky Joseph M.Chief Financial OfficerFeb 13 '26Buy23.663,37079,74210,290Feb 13 12:44 PM
Blaser Brian J.President and CEOFeb 13 '26Buy23.5910,540248,66140,073Feb 13 10:43 AM
RHOADS ANN DDirectorDec 10 '25Buy28.2775021,20615,021Dec 10 06:37 PM
Wilkins Joseph D Jr.DirectorNov 26 '25Buy27.9537010,34311,876Dec 01 04:33 PM
WIDDER KENNETH JDirectorNov 25 '25Option Exercise15.747,021110,51141,087Nov 25 04:16 PM
WIDDER KENNETH JDirectorNov 25 '25Sale27.814,026111,96537,061Nov 25 04:16 PM
KENNETH WIDDERDirectorNov 25 '25Proposed Sale27.814,026111,965Nov 25 04:11 PM
Busky Joseph M.Chief Financial OfficerNov 24 '25Buy26.064,770124,3056,920Nov 25 01:21 PM
POLAN MARY LAKE PH DDirectorNov 21 '25Buy22.431,00022,43012,640Nov 24 04:09 PM
Blaser Brian J.President and CEONov 19 '25Buy21.3423,500501,57729,533Nov 20 04:16 PM
QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.
PresidentMr. Brian J. Blaser
Chief Operations OfficerMr. Philip D. McLellan
Executive VP of Research & Development and CTOMr. Jonathan P. Siegrist Ph.D.
Chief Financial Officer & Principal Financial OfficerMr. Micah Young CPA
Vice President of Investor RelationsMs. Juliet C. Cunningham